Top

Published in:

01-12-2015 | Original Article

Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study

Authors: Yasemin Eren, Ebru Dirik, Salim Neşelioğlu, Özcan Erel

Published in: Acta Neurologica Belgica | Issue 4/2015

Abstract

Although migraine is a neurological disorder known since long, its physiopathology remains unclear. Recent studies suggest that migraine is associated with oxidative stress; however, they report divergent results. The aim of the present study was to evaluate total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), and serum thiol level in migraine patients with or without aura. The study group consisted of 141 migraine patients. The control group included 70 healthy subjects. TAS, TOS, OSI were evaluated using a method developed by Erel. Serum thiol level was measured using the Hu method. No difference was found in TAS, TOS, OSI between the patients and controls. The level of thiol was significantly lower in patients than in controls. Negative correlations were detected between thiol level and Migraine Disability Assessment score in patients. Although TAS, TOS, and OSI were similar to those of the control group, serum thiol level, an important marker of antioxidant capacity, was significantly lower in migraines compared with controls, and caused more serious disability. Novel treatment approaches may be developed based on these data, and compounds containing thiol, such as alpha lipoic acid and N-acetyl cysteine, may be used in prophylaxis.

Bockwski L, Sobaniec W, Kulak W et al (2008) Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 60:542–548

Gruber HJ, Bernecker C, Lechner A et al (2010) Increased nitric oxide stress is associated with migraine. Cephalalgia 30:486–492PubMed

Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478CrossRefPubMed

Atmaca G (2004) Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 45:776–788CrossRefPubMed

Cadenas E (1989) Biochemistry of oxygen toxicıty. Annu Rev Biochem 58:79–110CrossRefPubMed

Pasaoglu H, Sancak B, Bukan N (2004) Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 203:211–218CrossRefPubMed

Yilmaz N, Aydin O, Yegin A et al (2011) Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 44:832–837CrossRefPubMed

Erel O (2004) A novel automated direct measurement method fortotal antioxidant capacity using a new generation, morestable ABTS radical cation. Clin Biochem 37:277–285CrossRefPubMed

Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMed

10.

Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 4:9–160

11.

Stewart WF, Lipton RB, Dowson AJ et al (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56:S20–S28CrossRefPubMed

12.

Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70–77CrossRefPubMed

13.

Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:380–385CrossRefPubMed

14.

Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain. doi:10.1016/j.pain.2013.07.021 PubMedCentral

15.

Glaubic-Łatka M, Łatka D, Bury W et al (2004) Current opinions on migraine pathophysiology. Neurol Neurochir Pol 38:307–315PubMed

16.

Lance JW (1993) Current concepts of migraine pathogenesis. Neurology 43:S11–S15CrossRefPubMed

17.

Uzar E, Evliyaoglu O, Toprak G et al (2011) Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 12:239–243PubMedCentralCrossRefPubMed

18.

Yilmaz G, Sürer H, Inan LE et al (2007) Increased nitrosative and oxidative stress in platelets of migraine patient. Tohoku J Exp Med 211:23–30CrossRefPubMed

19.

Shimomura T, Kowa H, Nakamo T et al (1994) Platelet superoxide dismutase in migraine and tension type headache. Cephalalgia 14:215–218CrossRefPubMed

20.

Tozzi-Ciancarelli MG, De Matteis G, Di Masimo C et al (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17:580–584CrossRefPubMed

21.

Ciancarelli I, Tozzi-Ciancarelli MG, Di Masimo C et al (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23:39–42CrossRefPubMed

22.

Tuncel D, Tolun FI, Gokce M et al (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126:92–97CrossRefPubMed

23.

Bolayir E, Celik K, Kugu N et al (2004) İntra erythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc 67:263–267PubMed

24.

Shukla R, Barthwal MK, Srivastava N et al (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 24:37–43CrossRefPubMed

25.

Alp R, Selek S, Alp SI et al (2010) Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 14:877–882PubMed

26.

Morıarty-Craıge SE, Jones D (2004) Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr 24:481–509CrossRefPubMed

27.

Liu J, Wang X, Shigenaga MK et al (1996) Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of the rats. FASEB J 10:1532–1538PubMed

28.

Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363CrossRefPubMed

29.

Deneke SM (2000) Thiol-based antioxidants. Curr Top Cell Regul 36:151–180CrossRefPubMed

30.

Wlodek L (2002) Beneficial and harmful effects of thiols. Pol J Pharmacol 54:215–223PubMed

31.

Levine RL, Williams JA, Stadtman ER et al (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:347–357

32.

Ciancarelli I, Tozzi-Ciancarelli MG, Di Masimo C et al (2004) Flunarizine effects on oxidative stress in migraine patients. Cephalalgia 24:528–532CrossRefPubMed

Title: Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study
Authors: Yasemin Eren
Ebru Dirik
Salim Neşelioğlu
Özcan Erel
Publication date: 01-12-2015
Publisher: Springer Milan
Published in: Acta Neurologica Belgica / Issue 4/2015
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-015-0427-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Reassessment of Lhermitte’s sign in multiple sclerosis

Compulsion in a different artistic format for a patient with FTD

De novo formation and rupture of proximal anterior cerebral artery aneurysm associated with middle cerebral artery occlusion

Hippocampal diffusion tensor imaging microstructural changes in vascular dementia

Tuberothalamic infarction causing a central Horner syndrome with contralateral ataxia and paraphasia

Febrile Hashimoto’s encephalopathy associated with Hashitoxicosis